www.bioaccessla.com Open in urlscan Pro
99.83.177.15  Public Scan

Form analysis
0 forms found in the DOM

Text Content

0

The International Business Times has published an article about our work in
helping Medtech companies develop their clinical plans in Latin America. Check
it out!

Skip to Content



Home
Solutions
Services
About
Resources
News
Blog
Testimonials
FAQ
Podcast
Careers
CONTACT US
Open Menu Close Menu

Home
Solutions
Services
About
Resources
News
Blog
Testimonials
FAQ
Podcast
Careers
CONTACT US
Open Menu Close Menu

Home
Solutions
Services
About
Folder: Resources
Podcast
Careers
CONTACT US
Back
News
Blog
Testimonials
FAQ


YOUR GATEWAY TO ACCELERATED MEDTECH CLINICAL STUDY RESULTS

LATIN AMERICA’S LEADING CONTRACT RESEARCH ORGANIZATION (CRO) PROVIDES
WORLD-CLASS CLINICAL RESEARCH SERVICES, RAPIDLY ADVANCING YOUR MEDICAL DEVICE
FROM PILOT STUDY TO COMMERCIALIZATION


BIOACCESS® BRINGS CERTAINTY

We at bioaccess® are experts in delivering cost-effective, high-quality medical
device CRO services in Latin America. We collaborate with Medtech startups
seeking accelerated clinical study results.

With bioaccess® , you quickly and reliably receive regulatory approval, clinical
research site activation, subject recruitment, and trial data.

We bring you certainty in:

✔️ Moving to the next phase (an FDA IDE pivotal study)

✔️ Raising funds

✔️ A successful exit

LEARN MORE


ADVANCE YOUR MEDICAL DEVICE SOONER



Pilot Studies



Early-Feasibility Studies (EFS)



First-In-Human Studies (FIH)



Pivotal Studies



Post-Market Clinical
Follow-Up (PMCF)

Medtech clinical trials require high experience levels, specialized knowledge,
and flexibility. 

Our clinical research team is composed of experts with a proven background of
20+ years in Medtech, focused only on:

 * Early-Feasibility Studies (EFS)

 * First-In-Human Studies (FIH)

 * Pilot Studies

 * Pivotal Studies

 * Post-Market Clinical Follow-Up Studies (PMCF)

bioaccess® has the expertise and customized approach you need to advance your
medical device sooner.

VIEW SERVICES


TRUSTED BY

Slide 1 Slide 1 (current slide)

Slide 2 Slide 2 (current slide)

Slide 3 Slide 3 (current slide)

Slide 4 Slide 4 (current slide)

Slide 5 Slide 5 (current slide)

Slide 6 Slide 6 (current slide)

Slide 7 Slide 7 (current slide)

Slide 8 Slide 8 (current slide)



Testimonials

 * “I'm very grateful for the work you've done. I'm beyond impressed by the team
   you've assembled and the depth of research that you did. I've worked with
   other consultants before in various projects, and they 'll shortcut a lot of
   the diligence that needs to be done to truly understand the market. You've
   exceeded my expectations on the depth of research. I've been impressed with
   the process.”
   
   Tony Recupero
   
   President, Commercial Operations at SI-BONE
   
   

 * “In my short time at ReGelTec, Cris Venner at bioaccess® has been fantastic
   to work with. She is doing a great job, and no matter how often I send her a
   message on WhatsApp (which is a lot) with a request, she always responds
   quickly and gets me what I need (with a positive attitude). For example, I
   sent Cris a message a little after 8 AM for an urgent request (needing
   something for a 10 AM meeting), and she quickly got me everything I needed.
   Cris and the rest of the team at bioaccess® make this process easy for me
   because managing an OUS clinical study isn't easy. I just wanted to make sure
   you knew how much I value Cris and her great job.”
   
   Robert Townsend
   
   Senior Director Clinical Affairs ReGelTec, Inc.

 * “Obtaining approval for a foreign study is always a challenge. bioaccess's
   assistance was invaluable in getting our study approved in Colombia. In
   addition to having an in-depth knowledge of the regulatory approval process,
   they also have a deep understanding of the culture. As a result, bioaccess™
   can identify and troubleshoot potential problems before they arise. For
   companies considering a trial in Colombia, I recommend bioaccess™ without
   hesitation.”
   
   Robert Berman
   
   CEO at enVVeno Medical Corporation




Item 1 of 3


COMMITTED TO YOUR SUCCESS

bioaccess® is a US-based CRO that bridges the gap between innovative Medtech
companies and the untapped potential of conducting clinical research studies in
Latin America.

Our team believes in the importance of your medical device and the benefit it
could bring to people’s lives.

We are committed to helping you navigate the convoluted and uncertain
developmental challenges of being an early-stage startup. Our priority is
bringing you fast, cost-effective, and high-quality clinical data.

LEARN MORE


IMH ASSETS CORP (dba bioaccess®) 
1200 Brickell Avenue, Suite 1950 #1034, Miami, FL 33131

166 Geary Street, 15th Floor #1181, San Francisco, CA 94108

--------------------------------------------------------------------------------

Testimonials

Services

Home

Podcast

FAQ

About

Solutions

News

Blog

Contact

CONTACT US:

BOOK A MEETING | E-MAIL | CALL US: +1 (305) 539-9106‬



--------------------------------------------------------------------------------


Copyright © 2024 IMH ASSETS CORP. All rights reserved. bioaccess® is a
registered trademark of IMH ASSETS CORP.



×


NOTICE

We and selected third parties collect personal information and use cookies or
similar technologies for technical purposes and, with your consent, for
functionality, experience, measurement and “marketing (personalized ads)”.

With respect to advertising, we and 917 selected third parties, may use precise
geolocation data, and identification through device scanning in order to store
and/or access information on a device and process personal data like your usage
data for the following advertising purposes: personalised advertising and
content, advertising and content measurement, audience research and services
development.

You can freely give, deny, or withdraw your consent at any time by accessing the
preferences panel. If you give consent, it will be valid only in this domain.
Denying consent may make related features unavailable.



Use the “Accept” button to consent. Use the “Reject” button or close this notice
to continue without accepting.

Press again to continue 0/1
Learn more and customize
RejectAccept

BOOK A MEETING